Skip to content

Clinical trials

Terminated Phase 1/2 Nasopharyngeal Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Phase: Phase 1/2 Status: Terminated Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20171
20192
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Proton and Heavy Ion Center2
Atara Biotherapeutics1
Cullinan Therapeutics Inc.1
Genmab1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma6
Epstein-Barr Virus Infections2
Nasopharyngeal Neoplasms2
Carcinoma1
Carcinoma, Renal Cell1
Head and Neck Neoplasms1
Lymphoma, Non-Hodgkin1
Nasopharyngeal Diseases1
Neoplasms1
Neoplasms by Histologic Type1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.